Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Letters to the Editor

Beta-blocker use and survival in diffuse large B-cell lymphoma: a post hoc analysis of the RICOVER-60 trial

Department of Internal Medicine I (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical Center, Homburg/Saar, Germany; Center for Hematology and Oncology Bethanien, Frankfurt am Main
Department of Internal Medicine III, (Cardiology, Angiology, Intensive Care Medicine), Saarland University, Saarland University Medical Center, Homburg/Saar
Department of Internal Medicine I (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical Center, Homburg/Saar
Department of Internal Medicine I (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical Center, Homburg/Saar
Department of Internal Medicine III, (Cardiology, Angiology, Intensive Care Medicine), Saarland University, Saarland University Medical Center, Homburg/Saar, Germany; HOMICAREM (HOMburg Institute for CArdioREnalMetabolic Medicine), Universitätsklinikum des Saarlandes, Saarland University, Homburg
Department of Internal Medicine I (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical Center, Homburg/Saar
Department of Internal Medicine I (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical Center, Homburg/Saar
Department of Internal Medicine I (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical Center, Homburg/Saar
Department of Internal Medicine I (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical Center, Homburg/Saar
Department of Internal Medicine I (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical Center, Homburg/Saar
Department of Internal Medicine I (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical Center, Homburg/Saar
Department of Internal Medicine III, (Cardiology, Angiology, Intensive Care Medicine), Saarland University, Saarland University Medical Center, Homburg/Saar
HOMICAREM (HOMburg Institute for CArdioREnalMetabolic Medicine), Universitätsklinikum des Saarlandes, Saarland University, Homburg
Department of Internal Medicine I (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical Center, Homburg/Saar
Department of Internal Medicine I (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical Center, Homburg/Saar
Haematologica Early view Oct 29, 2026 https://doi.org/10.3324/haematol.2026.301369

This article has no abstract. The full text is available in PDF.

Download PDF

Figures & Tables

Article Information

Early view : Letters to the Editor
 
DOI
https://doi.org/10.3324/haematol.2026.301369
Pubmed
42952449
 
Published
2026-10-29
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2026 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
214
PDF Downloads
115
No Data
PlumX
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2026 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online